Speciality: Pharmacy
Description:
In today’s episode, let’s unravel the role of generic medicines in making healthcare more affordable. Generic medicines are essentially copies of brand-name drugs, containing the same active ingredients, strength, and dosage form. They work in the same way and offer the same clinical benefits as their branded counterparts, but usually at a much lower cost. This cost-effectiveness comes from reduced research and development expenses, as generics are produced after the original drug’s patent expires. By choosing generic medicines, patients and healthcare systems can save significant amounts, improving access to essential treatments for more people. So, the next time you get a prescription, consider asking your healthcare provider about generic options—they are safe, effective, and wallet-friendly.
See More Webinars @ Hidoc Webinars
1.
Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?
2.
No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.
3.
Biomarker panel offers hope for early pancreatic cancer detection
4.
Financial hardship common in patients with cancer
5.
New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.
1.
What You Need To Know About Secondary Polycythemia: Treatment & Symptoms
2.
Emerging Methods in Hematology in Clinical Decision-Making
3.
Fatigue Rehabilitation in Blood Disorders
4.
Digital Morphology Libraries for Hematology Education: Transforming Diagnostic Training and Clinical Practice
5.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
2.
Early Cancer Detection Saves Lives
3.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
4.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation